Cytokines in the colon of a patient with Behçet's disease

Arthritis Research and Therapy

Volumn 11, Issue 4, 2009, Pages

  Kappen, Jasper H ^a   Dik, Willem A ^a   Dingjan, Gemma M ^a   van Daele, Paul L ^a   Hooijkaas, Herbert ^a   Martin, Martin P ^a   van Laar, Jan A M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CYTOKINE; ETANERCEPT; GAMMA INTERFERON; IMMUNOGLOBULIN; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 17; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; ANTIINFLAMMATORY AGENT;

ADULT; ANTIBODY DETECTION; ARTICLE; BEHCET DISEASE; CASE REPORT; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOSE RESPONSE; DRUG MEGADOSE; DRUG TREATMENT FAILURE; GENE EXPRESSION; GENERAL CONDITION IMPROVEMENT; HEMICOLECTOMY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; RELAPSE; TH1 CELL; TH17 CELL; COLON; IMMUNOLOGY; MALE; NOTE;

ADULT; ANTI-INFLAMMATORY AGENTS; BEHCET SYNDROME; COLITIS; COLON; CYTOKINES; HUMANS; MALE; RNA, MESSENGER;

EID: 70049113644     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2784     Document Type: Article

References (4)

1. Cañete JD Celis R Noordenbos T Moll C Gómez-Puerta JA Pizcueta P Palacin A Tak PP Sanmartí R Baeten D Distinct synovial immunopathology in Behçet disease and psoriatic arthritis Arthritis Res Ther 2009, 11:R17 2688249 19196489 10.1186/ar2608
2. Dik WA Nadel B Przybylski GK Asnafi V Grabarczyk P Navarro JM Verhaaf B Schmidt CA Macintyre EA van Dongen JJ Langerak AW Different chromosomal breakpoints impact the level of LMO2 expression in T-ALL Blood 2007, 110:388-392 10.1182/blood-2006-12-064816 17360939
3. Yazici H Fresko I Yurdakul S Behçet's syndrome: Disease manifestations, management, and advances in treatment Nat Clin Pract Rheumatol 2007, 3:148-155 10.1038/ncprheum0436 17334337
4. van Laar JA Missotten T van Daele PL Jamnitski A Baarsma GS van Hagen PM Adalimumab: A new modality for Behçet's disease? Ann Rheum Dis 2007, 66:565-566 10.1136/ard.2006.064279 17124248